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Abstract 
The role of lysines 2 and 81 as target sites for acetylation in full-length HMGB1 and 
truncated tail-less protein, respectively, has been studied by mutation analysis for the 
abilities of these proteins to bind and bend DNA. The DNA bending ability of truncated 
tail-less HMGB1 containing Lys-2 mutated to alanine does not differ from that of the 
wild-type protein, while the same mutation of Lys-81 reduced the bending capacity of 
the mutant protein. These data demonstrate that Lys-81 is critical for the DNA bending 
ability of truncated HMGB1. Such a conclusion is further confirmed by the experiments 
carried  out  with  CBP-acetylated  proteins:  acetylation  of  Lys-2  in  mutant  protein 
K81/A81 alleviated DNA bending and induced DNA end-joining. On the contrary, the 
acetylation of Lys-81 in the mutant K2/A2 enhanced the bending potential of HMGB1∆C. 
Regarding the ability of HMGB1 to specifically bind bent DNA, the individual mutations 
of either K2 or K81 as well as the double mutation of both residues to alanine were found 
to completely abolish binding of truncated tail-less HMGB1 to cisplatin-modified DNA. 
We conclude that unlike the case with the bending ability of truncated HMGB1, where 
Lys-81 has a primary function, Lys-2 and Lys-81 are both critical for the protein’s binding 
to cisplatin-modified DNA. The mutation K2/A2 in full-length HMGB1 and acidic tail 
removal induce the same conformational changes. Any further substitutions at the acet-
ylable lysines in the truncated form of HMGB1 do not have an additional effect. 
Key  words:  HMGB1  protein,  tail-less  HMGB1  protein,  Lys-2  and  Lys-81  residues,  acetylation, 
binding to platinated DNA, DNA bending. 
Introduction 
The high mobility group box protein 1 (HMGB1) 
is an abundant non-histone protein of chromatin with 
rather unusual biology. It is composed of two tandem 
DNA binding HMG-box domains (N-terminal A and 
central  B),  and  an  acidic  C-terminal  tail,  mediating 
protein-protein interactions [1-3]. This structure con-
fers  HMGB1  the  peculiar  feature  to  recognize  and 
specifically  bind  DNA  structures,  containing  sharp 
bends or kinks, such as four way junctions [4], DNA 
damaged by the anticancer drug cisplatin [5, 6] and by 
UV-light [7], or to induce bending in linear duplex 
DNA  [8,  9].  The  structure-specific  DNA  binding  is 
attributed to the A box [9, 10] while the DNA bending 
capacity is primarily related to the B domain [11]. The 
abilities of HMGB1 to bend DNA and to bind bent 
DNA  define  this  protein  as  an  architectural  factor, 
promoting the assembly of nucleoprotein complexes 
[2].  This  crucial  role  explains  the  implication  of 
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HMGB1  in  mediating  fundamental  cellular  events 
such as transcription, recombination, replication and 
repair [3]. One way for regulation of such a role is the 
posttranslational  modification(s),  mainly  acetylation 
and phosphorylation. Regarding acetylation, in spite 
of  the  very  early  identification  of  Lys-2  as  a  main 
acetylation site in the protein from calf thymus [12], 
attempts to evaluate the consequences of this modifi-
cation  for  the  properties  of  HMGB1  were  initiated 
much later. In vivo modified protein, isolated from 
butyrate-treated  cells  and  shown  to  be  monoacety-
lated at Lys-2 [13], demonstrated an enhanced bind-
ing affinity to distorted DNA structures [13], inability 
to bend DNA and, instead, an increased capacity to 
stimulate  joining  of  DNA  fragments  via  their  ends 
[14].  Furthermore,  acidic  tail  removal  by  tryptic 
cleavage was found to create another site for acetyla-
tion, Lys-81 [15]. In vitro acetylation of this target site 
in  truncated  tail-less  HMGB1  restored  the  protein’s 
bending  ability  and  strongly  reduced  the  DNA 
end-joining  activity  [14].  Acetylation  of  Lys-81, 
therefore,  completely  alleviated  the  effects  obtained 
upon acetylation of Lys-2. 
Given  the  data  on  the  role  of  acetylation  of 
HMGB1  protein  for  its  architectural  properties,  our 
next aim was to assess the individual contribution of 
Lys-2 and Lys-81 in this regard. To this end, recom-
binant  full-length  and  truncated  tail-less  HMGB1 
were obtained as well as mutant proteins in which the 
acetylatable lysine residues were replaced by alanine: 
Lys-2 in full length protein and Lys-2 or/and Lys-81 
in the truncated tail-less HMGB1. The proteins gen-
erated were analysed to explore their contribution to 
DNA binding specificity and bending ability. The data 
obtained suggest a critical role for K81 in the linker 
region between A and B box for the architectural ca-
pacity of the tail-less HMGB1. It should be stressed 
here, that the truncated tail-less protein should not be 
regarded  solely  as  an  artificial,  in  vitro  generated 
protein. A trypsin-like chromatin-bound protease has 
been identified that specifically cleaves the acidic tail 
of  HMGB1  [16].  Moreover,  proteins  with  truncated 
C-terminal domain called HMG3 were purified from 
calf thymus [17] and various tumor cell lines [18]. 
Materials and methods 
 Polymerase chain reaction (PCR) 
DNA  constructs  for  full-length  recombinant 
HMGB1, its truncated tail-less molecule (HMGB1∆C), 
their single mutants HMGB1(K2/A2), HMGB1(К81/ 
А81),  HMGB1∆C(К2А/A2),  HMGB1∆C(К81/А81) 
and the double mutant HMGB1∆C(К2/А2, K81/A81) 
were  prepared  by  PCR  amplification  of  cDNA  en-
coding full-length rat HMGB1 (lib.N 961, RZPD) as 
described [19]. The primers used introduce EcoR1 and 
XhoI cloning sites for the full length HMGB1 forward 
5’-TGCACTGGAATTCATGGGCAAAGGAGATCC-3
’  and  reverse  5’-CAGTGCACTCGAGTTATTCATC 
ATCATCATCTTC-3’  and  for  the  truncated  form 
HMGB1∆C forward 5’-TGCACTGGAATTCATGGGC 
AAAGGAGATCC-3’  and  reverse  5’-CTTCTTT 
TTCTTGCTTTTTTCAGCCTTG-3’  respectively.  The 
substitution  of  K2  to  A2  in  full  length 
HMGB1(K2/A2)  and  tail-less  HMGB1∆C(К2/A2) 
proteins  was  generated  by  primers  bearing  the  ap-
propriate  mutation:  forward  5’-TGCACTGGA 
ATTCATGGGCGCAGGAGATCC-3’  for  both  pro-
teins  and  reverse  5’-CAGTGCACTCGAGTTATT 
CATCATCATCATCTTC-3’  for  the  full  length  and 
reverse  5’-CTTCTTTTTCTTGCTTTTTTCAGCCTTG 
-3’ for the truncated protein respectively. For the sub-
stitution  of  K81  to  A81  in  full  length 
HMGB1(K81/A81)  and  tail-less  HMGB1∆C(К281/ 
A81)  proteins  several successive  PCRs  were  carried 
out. First the DNA coding amino acid sequences from 
1 to 86 for both protein preparations was amplified 
with  forward  primer  bearing  EcoR1  restriction  site 
(5’-TGCACTGGAATTCATGGGCAAAGGAGATCC-
3’) and a reverse one bearing a mutation at Lys 81 
(5’-CTTTTTTGTTTCCCCTGCGGGAGGGATATAGG
T -3’). In a second PCR a DNA fragment coding amino 
acids from 74 to 186 was synthesized by a forward 
primer  introducing  a  mutation  at  Lys  81 
(5’-ACCTATATCCCTCCCGCAGGGGAAACAAAA
AAG-3’)  and  a  reverse  one  with  a  Xho1  restriction 
sequence  (5’-CAGTGCACTCGAGTTATTCATCAT 
CATCATCTTC-3’)  for  the  full  length  HMGB1  and 
(5’-CAGTGCACTCGAGCTTCTTTTTCTTGCTTTTTT
CAGCC-3’) for the truncated form respectively. The 
overlapping DNA fragments were used as a template 
for a third PCR resulting in the entire DNA length for 
HMGB1(K81/A81)  and  HMGB1∆C(К281/A81)  by 
incubating  it  with  primers  forward  5’-TGCACT 
GGAATTCATGGGCAAAGGAGATCC-3’  and  re-
verse  5’-CAGTGCACTCGAGTTATTCATCATCA 
TCATCTTC-3’  and  forward  5’-TGCACTGGA 
ATTCATGGGCAAAGGAGATCC-3’  and  reverse 
5’-CTTCTTTTTCTTGCTTTTTTCAGCCTTG-3’  re-
spectively.  The  double  mutant 
HMGB1ΔCK2/A2K81/A81 was created as above ex-
cept  that  for  the  amplification  of  the  first  fragment 
(1–86  a.a.)  a  forward  primer  bearing  a  mutation  at 
Lys2  and  EcoR1  restriction  site  was  used 
(5’-TGCACTGGAATTCATGGGCGCAGGAGATCC-
3’). The PCR was carried out in a 50 µl final volume 
using  QB-96  thermocycler  (LKB).  The  reaction  mix-
ture contained: 0.125 mM MgCl2, 0.25 mM dNTP, 2 Int. J. Biol. Sci. 2011, 7 
 
http://www.biolsci.org 
693 
µM of the appropriate primers, 50 ng matrix DNA, 2 
units Taq polymerase (Pharmacia) and 5 µl 10 x PCR 
buffer.  The  purity  of  all  DNA  preparations  was 
checked by agarose gel electrophoresis and the accu-
racy  of  the  obtained  constructs  was  proved  by  se-
quencing analysis on ABI PRISM 3100 Genetic Ana-
lyzer. 
Expression of recombinant proteins  
The  PCR  products  were  treated  with  the  re-
striction enzymes EcoR1 and XhoI, cloned in an ex-
pression vector pET28a+ and expressed in modified 
Escherichia coli BL21  Poly  Lys  S.  His-tagged  protein 
samples were purified on a HIS-Select HF Nickel Af-
finity gel (Sigma). Before His-tag removal the proteins 
were loaded on the Nickel Affinity gel equilibrated 
with 20 mM Tris–HCl, pH 7.9 containing 60 mM im-
idazole, 50 mM NaCl and the slurry was washed with 
thrombin cleavage buffer (20 mM Tris–HCl, pH 8.4, 
150 mM NaCl, 2.5 mM CaCl2) supplemented with 0.5 
units of thrombin (human plasma, Calbiochem) per 
milligram recombinant protein and incubated for 4 h. 
at  room  temperature.  After  brief  centrifugation  the 
supernatant containing the His-tag depleted protein 
was collected and used for further experiments. The 
purity  of  all  protein  preparations  was  checked  by 
polyacrylamide  gel  electrophoresis  containing  sodi-
um dodecyl sulfate (SDS- PAGE).  
 Acetylation assay 
Expression and purification of recombinant his-
tone acetyltransferase CBP together with the protocol 
of the acetylation procedure in the presence of acetyl 
CoA are described in [15]. For each protein prepara-
tion  the  histone  acetyltransferase  (HAT)  assay  was 
first carried out on filters using radioactive [14C] acetyl 
CoA to confirm the proteins’ modification. Briefly, the 
filter binding assay was performed in 20µl of reaction 
mixture  using  100  pmol  of  [14C]  acetyl-CoA  (3.5 
mCi/mmol, Amersham Life Science Inc.). All protein 
substrates including histones H3/H4 were added to a 
concentration of 0.033µg/ml. After incubation at 30 °C 
for 40 min, the reaction mixture was spotted onto a 
Whatman P-81 phosphocellulose filter, and following 
four washes with sodium carbonate buffer, pH 9.2, the 
filters were dried and counted in a liquid scintillation 
counter.  The  level  of  acetylation  of  the  tail-less 
HMGB1 protein and its mutant forms corresponded 
to  the  previously  reported  [19],  compared  to  the 
modification  level  of  recombinant  H3/H4  and  pre-
sented on Fig.2. For the ligase-mediated circulariza-
tion assay and electrophoretic mobility shift assay all 
protein  samples  were  acetylated  in  the  presence  of 
cold acetyl CoA. 
Ligase-mediated circularization assay 
 The  DNA  probe  used  was  a  111-bp  fragment 
obtained by BamH1 and PvuII digestion of pUC19 and 
labeled  with  [α-32P]dCTP.  The  assay  generally  fol-
lowed  a  procedure  described  elsewhere  [8].  After 
termination of ligation, the samples were fractionated 
by 5% PAGE as described [15]. After the electropho-
resis,  the  gels  were  dried  and  autoradiographed. 
Generated circles were identified in the gel by their 
resistance to exonuclease III digestion. 
Electrophoretic mobility shift assay (EMSA)  
The analysis was carried out as described pre-
viously [7] using a 32P-labeled 40-bp oligonucleotide, 
site specifically platinated at a single GpG inserted in 
a restriction site for BamH1 endonuclease [13]. 
Circular Dichroism measurements (CD)  
CD  spectra  were  measured  with  step  mode 
(bandwidth 2 nm, data interval 0.1 nm, response time 
0.125 sec) in a J-810 CD spectrometer (Jasco, Japan). 
The  temperature  of  measurements  was  set  at  150C 
using Peltier effect temperature controller. The spec-
tra were averaged over 3 scans to increase the signal 
to  noise  ratio.  Thermal  unfolding  of  proteins  was 
monitored by change in CD signal at 222 nm (band-
width 5nm, data interval 1/sec, response time 0.5 sec) 
upon temperature elevation from 15 to 700C with a 
rate 100C/min. A 1x0.2 cm mini quartz cell with four 
windows (Hellma, Germany) was used. The cell per-
mits to measure the CD signal either with 1 cm or 0.2 
cm path length. The spectra were measured with 0.2 
cm path length to get signal also at far-UV region and 
the thermal folding with 1 cm path length to get larger 
signal. 
Results and Discussion 
 Lysine residues 2 and 81 were mutated to ala-
nine either individually (K2/A2 or K81/A81) or to-
gether  (K2/A2,K81/A81)  in  the  truncated  HMGB1 
protein  lacking  the  acidic  C-domain  (HMGB1∆C). 
Regarding  the  full-length  protein,  a  K2/A2  mutant 
was  obtained  as  Lys-2  was  the  only  acetylable  site 
proved  so  far  [13].  We  generated  also  a  K81/A81 
substitution in the molecule of HMGB1, despite the 
fact that K81 was not modified by the acetyltransfer-
ase  CBP,  in  order  to  estimate  the  contribution  of 
Lys-81 to the architectural properties of the protein. 
As a result, seven recombinant HMGB1 proteins were 
created and the introduced mutations are schemati-
cally presented in Fig.1: wild-type full length HMGB1 
and  its  single  mutants  HMGB1K2/A2  and 
HMGB1K81/A81;  wild-type  truncated  HMGB1 
(HMGB1∆C),  its  single  mutants  HMGB1∆C(K2/A2) Int. J. Biol. Sci. 2011, 7 
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and HMGB1∆C(K81/A81), as well as the double mu-
tant HMGB1∆C(K2/A2, K81/A81). 
 
 
Fig.1. Schematic presentation of the mutations gener-
ated in the full length and tail-less HMGB1 protein. 
 
The role of Lys-2 and Lys-81 and their acetylation 
for the DNA bending activity of truncated tail-less 
HMGB1  
 Previous study on acetylation of HMGB1 from 
calf thymus identified lysine 2 as a main target site 
[12]  but  more  recent  in  vitro  experiments  demon-
strated that the removal of the acidic C-terminal tail 
exposed lysine 81 to this modification [15]. Our atten-
tion was focussed on K2 and K81 because they were 
the sites for acetylation in the truncated HMGB1. The 
acetylation  level  of  the  truncated  mutant  samples 
were  tested  as  in  [19]  and  the  results  presented  in 
Fig.2.  The  label  incorporation  in  HMGB1∆C  was 
comparable  to  that  of  the  classical  CBP  substrates 
H3/H4. The single mutant forms were less acetylated 
(~ 60%) which can be explained by the fact that one of 
the  target  lysine  resdue  (K2  or  K81)  was  omitted. 
Longer incubation time did not result in higher per-
centage  of  incorporated  radioactivity.  The  double 
mutant exhibited a background modification level.  
 
 
Fig.2. The acetylation level of the truncated HMGB1 
protein and its mutant forms. The protein samples are 
subjected  to  acetylation  by  CBP  using  [
14C]  acetyl 
CoA.The reaction mixtures were spotted onto a What-
man P-81 phosphocellulose filters,dried and counted in a 
liquid scintillation counter. 
 
The  consequences  of  the  mutations  K2/A2  or 
K81/A81  as  well  as  the  double  mutation 
K2/A2,K81/A81 and the contribution of the individ-
ual acetylation sites for the DNA bending ability of 
truncated  HMGB1  lacking  the  acidic  tail  were  ana-
lysed at two protein concentrations by the ring closure 
assay in the presence of DNA ligase (Fig.3).  
 
Fig.3.  DNA bending ability of various recombinant tail-less HMGB1 proteins (∆C), non-modified or in vitro CBP 
acetylated,  assayed  by  ligase-mediated  circularization  of  linear  111  bp  DNA.  Panel  A.  Generation  of  circular 
monomers (CM) and linear dimmers (LD) in the presence of various truncated tail-less HMGB1 proteins (HMGB1∆C). To 
simplify the presentation, ∆C stands for HMGB1∆C. ∆C, purified protein (lane 3); ∆C, di-acetylated at K2 and K81 
(lanes 4, 5); lane 6, control treatment with ExoIII to identify circular DNA; ∆CK2/A2 mutant, either non-modified 
(lane 7) or in vitro acetylated (lanes 8, 9); ∆CK81/A81 mutant, either non-modified (lane 10) or in vitro acetylated Int. J. Biol. Sci. 2011, 7 
 
http://www.biolsci.org 
695 
(lanes 11,12); lane 13, control treatment with ExoIII to identify linear DNA; ∆CK2/A2,K81/A81 double mutant, either 
non-modified (lane 14) or acetylated (lanes 15, 16). Panel B. Generation of CM by full-length wild-type HMGB1 (lane 
2), K2/A2 mutant (lane 3), K81/A81 mutant (lane 4), control treatment with ExoIII (lane 5), free DNA (lane 1). 
 
 
The tail-less protein showed an efficient bending 
ability (Fig.3, lane 3) in agreement with previous data 
that the acidic  tail is not necessary for the bending 
effect  [20].  Further  in  vitro  acetylation  of  truncated 
HMGB1 at both K2 and K81 with CBP was found to 
enhance the protein’s bending activity (Fig.3, compare 
lanes 4, 5 with lane 3). This finding confirms our ear-
lier data that the acetylated tail-less protein is more 
effective in inducing DNA bending than its unmodi-
fied counterpart [15]. Next, we analysed the effects of 
single  mutations  (K2/A2  or  K81/A81)  and  double 
mutation  (K2/A2,  K81/A81)  for  the  DNA  bending 
ability of truncated HMGB1. The data obtained  are 
rather  informative regarding  the  role  for  Lys-2  and 
Lys-81 in DNA bending. The bending activity of mu-
tant  protein  containing  K2  mutated  to  alanine 
(HMGB1∆CK2/A2)  is  similar  to  that  of  wild  type 
protein (Fig. 3, panel A, compare lanes 7 and 3), thus 
demonstrating that K2 is not essential for the bending 
capacity of truncated HMGB1. This conclusion is con-
firmed  by  the  data  obtained  with  truncated 
HMGB1∆C  in  which  K81  is  mutated  to  alanine 
(HMGB1∆CK81/A81): the mutant is much less effi-
cient  in  inducing  DNA  bending  than  the  wild-type 
truncated HMGB1 (HMGB1∆C) or the truncated pro-
tein containing K2 mutated to alanine (Fig. 3, compare 
lane 10 to lane 3 and lane 7, respectively). The protein 
containing  double  mutation  (HMGB1∆CK2/A2, 
K81/A81)  strongly  reduced  DNA  bending  activity 
(Fig. 3, lane 14). Some circular monomers were still 
visible which was not surprising as the functional B 
domain, responsible for the property of the protein to 
induce sharp angles in DNA, remains intact. Togeth-
er, this analysis and particularly the individual muta-
tions of Lys-2 and Lys-81 to alanine clearly demon-
strate that Lys-81 is critical for the DNA bending abil-
ity  of  truncated  HMGB1,  the  contribution  of  Lys-2 
being  much  less.  Such  a  conclusion  is  further  con-
firmed  by  the  experiments  carried  out  with 
CBP-acetylated proteins. Acetylation of K2 in mutant 
protein HMGB1∆CK81/A81 alleviated DNA bending 
and induced DNA end-joining (Fig. 3, lanes 11, 12; see 
also  ref.  [14]).  On  the  contrary,  the  acetylation  of 
Lys-81 in the mutant HMGB1∆CK2/A2 enhanced the 
bending potential of HMGB1 (Fig. 3, compare lane 8 
and 9 with lane 7). As expected, CBP acetylation of 
double mutant was without any effect on its proper-
ties (Fig.3, lanes 15, 16).  
The fact that the acetylable lysine residue at po-
sition 2 is not essential for the bending ability of the 
full length HMGB1 was shown also by a ring closure 
assay carried out with the recombinant HMGB1 and 
its  mutated  form  HMGB1K2/A2  (Fig.  3,  panel  B, 
compare lanes 2 and 3). In the HMGB1 molecule the C 
terminus overlaps the two HMG boxes and  shields 
the  Lys-81  from  acetylation  so  it  is  not  considered 
acetylable target site but still remains critical for the 
property of the protein to induce kinks in DNA (Fig. 
3, panel B, compare lanes 4 and 2).  
Following  the  demonstration  that  HMGB1  can 
efficiently bend DNA (8, 10, 11), this property of the 
protein was associated primarily with the B domain 
and its N-terminal and C-terminal flanking sequences 
(the full B domain, see ref. [11]). The investigations 
were mainly focused on the DNA binding motifs of 
the  protein,  its  HMG  boxes,  and  less  attention  was 
paid to the behaviour  of the linker basic sequences 
81KGETKKKFK89. The length of the inter-box linker in 
UBF (Upstream Binding Factor) was found critical for 
the relative box positioning and thus for ensuring an 
in-phase  bend  [21].  This  might  be  the  case  with 
HMGB1  protein  as  its  linker’s  length  in  different 
HMGB1 homologues is almost preserved (between −2 
and +3 amino acid residues) and the basic, lysine-rich 
sequence is conserved. The basic flanking sequences 
were  shown  to  stimulate  the  DNA  binding  of  the 
HMG box by providing additional DNA contacts, and 
thus required for optimal bending [22]. A more de-
tailed  analysis  on  the  linker/DNA  interactions  was 
reported by Stott et al. [23]. A protein construct that 
included the structured regions of the HMG box of 
SRY (sex-determining region on the Y chromosome) 
and  the  B  domain  of  HMGB1  plus  the  basic  linker 
region  was  generated.  The  interaction  of  the  SRY.B 
di-domain protein with DNA containing a SRY bind-
ing sequence ensured the formation of a well defined 
protein/DNA  complex.  The  NMR  analysis  proved 
that the linker was bound to the minor groove and 
especially that Lys-81 was in close contact with the 
DNA,  accomplished  through  deoxyribose  and  base 
interactions. This finding may support one possible 
explanation for the essential role of Lys-81 regarding 
the efficient DNA bending abilities of HMGB1. Any 
substitution or acetylation of Lys-81 will change its 
contacts with DNA thus affecting the property of the 
protein  to  induce  DNA  kink.  For  the  moment  we Int. J. Biol. Sci. 2011, 7 
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cannot definitely say on which step the acetylation of 
Lys-81 exerts its effect, whether the modification of 
K81 enhances HMGB1 binding to linear DNA or in-
fluences the HMGB1 bending property once the pro-
tein molecule is associated to DNA. We carried out 
gel-shift experiments with all protein preparations in 
their non-acetylated and acetylated forms but at the 
concentration used for the ring closure assay no com-
plex  with  linear  DNA  was  ever  detected  (data  not 
shown). 
Binding of full-length and truncated tail-less 
HMGB1 to cisplatin-damaged DNA is abolished 
upon mutation of Lys-2 and/or Lys-81 to alanine 
 Cisplatin-treated  DNA  is  a  widely  used  sub-
strate for illustration the ability of HMGB1 protein to 
preferentially  bind  distorted  DNA  structures  [1]. 
Here, this approach was used to evaluate the role of 
two lysine residues, K2 and K81 and their acetylation, 
for this particular property of HMGB1 and its trun-
cated form. The individual mutation of either K2 or 
K81 or double mutation of both residues to alanine 
were  found  to  completely  abolish  binding  of  trun-
cated tail-less HMGB1 to cisplatin-modified DNA as 
judged by EMSA (Fig.4, lanes 5, 7, 9). As far as these 
lysines are target sites for acetylation, a modification 
reported to strongly enhance the affinity of HMGB1 to 
cisplatinated DNA [13] we next attempted acetylation 
of the mutants with the transacetylase CBP, shown to 
acetylate the tail-less HMGB1 but not the full length 
molecule [15]. As far as the single mutation of K2 or 
K81  to  alanine  should  not  affect  the  possibility  for 
acetylation of the intact, non-mutated residue, it was 
intriguing  to  know  whether  such  a  possibility  has 
been actually realized. This was tested by gel retarda-
tion assay. Interestingly, following in vitro acetylation 
with CBP of each single mutant, unlike the data ob-
tained  with  wild  type  tail-less  protein  (Fig.4,  lanes 
2-4), band shifts have not been observed (Fig.4, lanes 
6, 8, 10). Moreover, it turned out that mutant trun-
cated  HMGB1  was  unable  to  bind  damaged  DNA 
even  though  the  non-mutated  lysine  of  the  protein 
had  been  acetylated  (see  Fig.2).  All  these  data 
demonstrate  that  the  acetylatable  lysine  residues  2 
and 81 in the tail-less HMGB1 are critical for the pro-
tein’s binding to cisplatin-modified DNA. It is worth 
mentioning,  that  the  same  results  have  been  regis-
tered with the single mutants K2/A2 and K81/A81 of 
full-length HMGB1 (Fig. 4, panel B, compare lane 2 
with 3 and 4). 
 
 
 
Fig.4. Electrophoretic mobility shift assay of the binding of various HMGB1 proteins to cisplatin-damaged DNA. 
Panel A. Interaction of wild-type tailless (∆C) protein (lanes 2 and 3), in vitro acetylated ∆C at K2 (lane 4), ∆CK2/A2 
mutant (lane 5), acetylated ∆CK2/A2 mutant (lane 6), ∆C K81/A81 mutant (lane 7), acetylated ∆CK81/A81 mutant 
(lane 8), ∆ K2/A2,K81/A81 double mutant (lane 9) and acetylated ∆CK2/A2K81/A81 mutant (lane 10). Lane 1 shows 
the position of free DNA. Panel B. Interaction of full-length HMGB1 (lane 2) and HMGB1K2/A2 and HMGB1K81/A81 
mutants (lanes 3 and 4 respectively) with cis-platinated DNA. Lane 1 shows the position of free DNA. 
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Mutations of Lys-2 have recently been used to 
analyse  the  role  of  this  residue  for  the  binding  of 
HMGB1 to distorted DNA structures [24]. Single mu-
tation of either K2 or K11 was reported to reduce the 
binding  affinity  relative  to  the  wild  type  protein, 
reaching full inhibition with double mutant protein. 
One explanation for the observed discrepancies might 
be the use of different substrates in the binding as-
says: cisplatin-damaged DNA (our experiment), and 
four-way  DNA  junctions  [24].  Considering  the  dif-
ferent effects of Lys-2/Lys-11 double mutation on the 
binding of the AB di-domain to four-way junction and 
to minicircles (a little effect, and ~15-fold reduction of 
binding, respectively, see ref. 24) of one hand and, of 
the  other,  the  observation  that  the  same  mutation 
abolished  binding  of  A  domain  to  both  four-way 
junctions and minicircles, such an explanation seems 
quite likely.  
CD and thermal stability analysis  
 The effects of mutations and C-terminal deletion 
on the protein structure were examined by CD meas-
urements, which are informative of the protein’s sec-
ondary  structure.  All  analysed  proteins  exhibited 
similar CD spectra (Fig. 5, panel A), indicating that 
neither the base substitution nor the acidic tail dele-
tion  affected  the  protein  secondary  structure.  Two 
negative peaks, one at 222 nm and another one at 205 
nm  were  observed,  corresponding  well  with  alpha 
helical folding. The absence of significant change in 
CD spectra indicates that the acidic tale has not par-
ticular secondary structure. The protein structure was 
further investigated by measuring the protein thermal 
stability, reflecting domain/domain contacts. Weak-
ening of these contacts usually decreases the protein 
stability. Wild-type protein was unfolded around 450 
with one main transition (Fig. 5, panel B), suggesting 
that the protein is folded in one domain or in domains 
nicely connected. The mutation of K2 to alanine de-
creased the thermal stability by about 60C, but there 
was always one main transition. The substitution de-
creased the global stability of protein but not the local 
stability  of  helical  folding  at  the  N-terminal  region 
where the substitution was made.  
  
 
 
Fig.5. The effect of C-tail removal and the substitution of acetylable lysines on the CD spectra and thermal stability 
of HMGB1protein. Panel A. CD spectra of wild type recombinant HMGB1 (black line), HMGB1K2/A2 (red up-triangles), 
recombinant HMGB1∆C (magenta down-triangles), HMGB1∆CK2/A2,K81/A81 (cyan crosses). Panel B. Thermal sta-
bility of wild type recombinant HMGB1 (black squares), HMGB1K2/A2 (red up-triangles), recombinant HMGB1∆C 
(magenta down-triangles), HMGB1∆CK2/A2,K81/A81 (cyan crosses).  
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The deletion of the acidic tail also decreased the 
stability in a very similar manner as did the substitu-
tion at the N-terminal part. Interestingly, the double 
mutation did not further destabilize the protein fold-
ing, suggesting that both modifications, K2 substitu-
tion and C-tail removal, destabilize the protein via the 
same  mechanism.  One  probable  explanation  is  that 
the two parts are involved in a contact between the C- 
and the N-terminal regions. The results, therefore, are 
in agreement with the idea that the acidic C-terminal 
tail makes extensive intramolecular contacts with the 
DNA binding surfaces of both HMG boxes [25-27] as 
well as with the recently reported evidence that the 
acidic tail is in physical contacts with Lys-2 [28]. It is 
reasonable to expect that acetylation of Lys-2 or its 
substitution with alanine may disrupt this contact. 
Conclusions 
Our results demonstrate that Lys-81 is critical for 
the ability of HMGB1 protein to induce sharp angles 
in DNA. The CBP acetylation of Lys-81 enhances the 
bending potential of the truncated protein lacking the 
acidic C-tail. The acetylable lysine residue at position 
2  is  not  important  for  the  bending  properties  of 
HMGB1 and its modification by CBP in the truncated 
form  stimulates  DNA  end-joining.  Both  lysine  resi-
dues, Lys-2 and Lys-81, turned out to be essential for 
the formation of a stable complex between HMGB1 
and  DNA  damaged  by  the  anti-tumor  drug 
cis-platinum. Their individual substitution by alanine 
entirely  abolished  the  affinity  of  the  protein  to 
cis-platinated DNA. Neither the acetylation at Lys-2 
in  HMGB1∆K81/A81  nor  at  Lys-81  in 
HMGB1∆CK81/A81 was able to overcome the inhib-
itory effect.  
There is increasing evidence for the modulating 
effect  of  the  post-synthetic  acetylation  of  HMGB1 
protein  especially  concerning  its  properties  as  an 
“architectural” factor. The individual impact of each 
of the acetylable lysines, modified or not, for the abil-
ity of the protein to bend and to bind with high affin-
ity  to  distorted  DNA  structures  will  provide  some 
clues for better understanding the role of HMGB1 in 
structural and functional aspect.  
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